The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14160%2F24%3A00135349" target="_blank" >RIV/00216224:14160/24:00135349 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.valuehealthregionalissues.com/article/S2212-1099(23)00089-4/fulltext" target="_blank" >https://www.valuehealthregionalissues.com/article/S2212-1099(23)00089-4/fulltext</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.vhri.2023.09.003" target="_blank" >10.1016/j.vhri.2023.09.003</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia

Popis výsledku v původním jazyce

Objectives: We have developed a scientifically well-grounded, methodological, and reporting checklist for economic evaluation (EE) of medicines in the Slovak health technology assessment process, which serves as a supplement to the Methods: The checklist was developed using an iterative process in which items were generated and gradually added to the baseline checklist based on shortcomings identified in an analysis of Slovak EEs, using relevant published checklists, and Slovak, as well as international, methodological guidance that was identified in the systematic literature review. The selection of checklist recommendations, their clarity, and relevance to the Slovak setting were validated in the online Results: From the sample of 151 price and reimbursement submissions published between January 2018 and July 2021, almost half of them (n = 73) received at least 1 request from the Ministry of Healthcare to justify or modify the methodology used in the EE; and in 18 proceedings, a negative opinion was issued because of shortcomings identified in the EE. The 25-items preliminary checklist, resulting from an iterative working process, has been validated in an online survey conducted among members of ISPOR Chapter Slovakia. After incorporating relevant comments, the final proposal for the Slovak checklist consists of 55 recommendations. Conclusions: The research represented the first attempt to create a Slovak EE checklist, which serves as a part of ISPOR Slovakia pharmacoeconomic guidelines. Implementation of the checklist allows checking whether EE meets legislative and methodological requirements and thus helps in improving the appropriateness and standardization of EEs in Slovakia.

Název v anglickém jazyce

The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia

Popis výsledku anglicky

Objectives: We have developed a scientifically well-grounded, methodological, and reporting checklist for economic evaluation (EE) of medicines in the Slovak health technology assessment process, which serves as a supplement to the Methods: The checklist was developed using an iterative process in which items were generated and gradually added to the baseline checklist based on shortcomings identified in an analysis of Slovak EEs, using relevant published checklists, and Slovak, as well as international, methodological guidance that was identified in the systematic literature review. The selection of checklist recommendations, their clarity, and relevance to the Slovak setting were validated in the online Results: From the sample of 151 price and reimbursement submissions published between January 2018 and July 2021, almost half of them (n = 73) received at least 1 request from the Ministry of Healthcare to justify or modify the methodology used in the EE; and in 18 proceedings, a negative opinion was issued because of shortcomings identified in the EE. The 25-items preliminary checklist, resulting from an iterative working process, has been validated in an online survey conducted among members of ISPOR Chapter Slovakia. After incorporating relevant comments, the final proposal for the Slovak checklist consists of 55 recommendations. Conclusions: The research represented the first attempt to create a Slovak EE checklist, which serves as a part of ISPOR Slovakia pharmacoeconomic guidelines. Implementation of the checklist allows checking whether EE meets legislative and methodological requirements and thus helps in improving the appropriateness and standardization of EEs in Slovakia.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30104 - Pharmacology and pharmacy

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Value in Health Regional Issues

ISSN

2212-1099

e-ISSN

—

Svazek periodika

39

Číslo periodika v rámci svazku

Januar

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

6

Strana od-do

14-19

Kód UT WoS článku

001117736600001

EID výsledku v databázi Scopus

—